Market News AIOpen the app

Cellyan Biotechnology's shares are back above $1.00, meeting Nasdaq's listing rules again.

RulesRead the original at globenewswire.com
Good for HKPD

HKPD regained Nasdaq’s minimum-bid requirement after shares stayed at or above $1.00 for 14 business days. The case is closed, removing the open listing problem despite its earlier 30 business days below $1.00.

HKPD · Cellyan Biotechnology Co., Ltd

AI read · Good for HKPD

The AI's read

This removes an open problem with HKPD’s Nasdaq listing. The earlier 30-business-day stretch below $1 shows its shares had fallen under the required price before recovering. The news helps its listing standing but says nothing about its business results.

Get alerts for HKPD

Follow Cellyan Biotechnology Co., Ltd (HKPD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HKPD
Free on the App Store and Google Play, or on the web.